Trading Strategy Guides
الذهاب إلى القناة على Telegram
📘Free Price Action Cheat Sheet: https://info.tradingstrategyguides.com/best-price-action-patterns-download?utm_source=telegram Website: https://tradingstrategyguides.com/
إظهار المزيد4 661
المشتركون
-324 ساعات
-37 أيام
-4130 أيام
جاري تحميل البيانات...
القنوات المماثلة
سحابة العلامات
الإشارات الواردة والصادرة
---
---
---
---
---
---
جذب المشتركين
يوليو '26
يوليو '26
+40
في 1 قنوات
يونيو '26
+44
في 0 قنوات
Get PRO
مايو '26
+48
في 0 قنوات
Get PRO
أبريل '26
+59
في 0 قنوات
Get PRO
مارس '26
+110
في 0 قنوات
Get PRO
فبراير '26
+38
في 0 قنوات
Get PRO
يناير '26
+45
في 0 قنوات
Get PRO
ديسمبر '25
+31
في 0 قنوات
Get PRO
نوفمبر '25
+30
في 0 قنوات
Get PRO
أكتوبر '25
+18
في 1 قنوات
Get PRO
سبتمبر '25
+10
في 1 قنوات
Get PRO
أغسطس '25
+14
في 0 قنوات
Get PRO
يوليو '25
+19
في 0 قنوات
Get PRO
يونيو '25
+25
في 0 قنوات
Get PRO
مايو '25
+12
في 0 قنوات
Get PRO
أبريل '25
+20
في 0 قنوات
Get PRO
مارس '25
+26
في 0 قنوات
Get PRO
فبراير '25
+15
في 0 قنوات
Get PRO
يناير '25
+58
في 1 قنوات
Get PRO
ديسمبر '24
+116
في 0 قنوات
Get PRO
نوفمبر '24
+68
في 0 قنوات
Get PRO
أكتوبر '24
+73
في 1 قنوات
Get PRO
سبتمبر '24
+116
في 1 قنوات
Get PRO
أغسطس '24
+167
في 1 قنوات
Get PRO
يوليو '24
+137
في 1 قنوات
Get PRO
يونيو '24
+143
في 1 قنوات
Get PRO
مايو '24
+162
في 0 قنوات
Get PRO
أبريل '24
+150
في 0 قنوات
Get PRO
مارس '24
+177
في 0 قنوات
Get PRO
فبراير '24
+119
في 0 قنوات
Get PRO
يناير '24
+5 581
في 0 قنوات
| التاريخ | نمو المشتركين | الإشارات | القنوات | |
| 25 يوليو | +1 | |||
| 24 يوليو | +2 | |||
| 23 يوليو | +1 | |||
| 22 يوليو | +1 | |||
| 21 يوليو | +2 | |||
| 20 يوليو | +4 | |||
| 19 يوليو | +3 | |||
| 18 يوليو | +4 | |||
| 17 يوليو | +1 | |||
| 16 يوليو | +1 | |||
| 15 يوليو | +3 | |||
| 14 يوليو | +2 | |||
| 13 يوليو | +3 | |||
| 12 يوليو | +3 | |||
| 11 يوليو | +1 | |||
| 10 يوليو | +1 | |||
| 09 يوليو | 0 | |||
| 08 يوليو | +2 | |||
| 07 يوليو | +1 | |||
| 06 يوليو | +1 | |||
| 05 يوليو | 0 | |||
| 04 يوليو | +1 | |||
| 03 يوليو | 0 | |||
| 02 يوليو | 0 | |||
| 01 يوليو | +2 |
منشورات القناة
📰 AI Stock Selloff: Why the Dip Is a Buy — July 25, 2026
The AI stock selloff resets overbought tech names on July 25, 2026. Here is why institutional traders are preparing to buy the dip when markets open Monday.
Read the full article ➜
| 2 |  📊 Ultimate Guide to the Hammer and Shooting Star Strategy
Master the hammer and shooting star strategy to spot high-probability price reversals, define exact risk levels, and capitalize on market rejections.
Read the full article ➜ | 73 |
| 3 |  🪙 Bitcoin Holds $64K as Corporate Treasury Pressure Builds
Bitcoin stays pinned around $64,130 while corporate treasuries unwind holdings and Ethereum searches for a cycle bottom.
Read the full article ➜ | 67 |
| 4 |  📋 Weekly Market Recap: July 20–July 24, 2026 — Tech Sell-Off Drags Indices Lower as Gold Shines
July 20–July 24, 2026: Tech sell-off drags major indices lower, Nasdaq 100 drops -3.08%, while Gold and Silver rally on safe-haven demand.
Read the full article ➜ | 74 |
| 5 |  📰 Oil Shock at $100: Stock Market Preview July 25, 2026
Crude oil reaches $100 per barrel as tariff threats re-emerge. Here is what traders need to watch for July 25, 2026.
Read the full article ➜ | 77 |
| 6 |  🎯 The Phantom Anchor: Capture High-Probability Reversals Off VWAP
The Phantom Anchor catches high-conviction intraday retests by pairing VWAP liquidity sweeps with Stochastic RSI momentum flips. Stop guessing reversals.
Read the full article ➜ | 85 |
| 7 |  📊 Pin Bar Reversal Strategy: The Complete Guide for Price Action Traders
Master the pin bar reversal strategy with exact setup criteria, entry rules, stop loss placement, and high-probability confluence factors.
Read the full article ➜ | 86 |
| 8 |  Verizon ($VZ) revealed it has signed a more than $1 billion agreement with Google to provide dark fiber connectivity linking the tech giant's data centers.
The deal marks a major step in Verizon's strategy to build a standalone enterprise connectivity business. Management said it expects to announce additional multi-billion-dollar connectivity agreements before year-end.
The company also reaffirmed its transformation momentum, targeting at least $9 billion in operating expense and capital expenditure savings, while noting its recently launched consumer value proposition is performing ahead of expectations. | 133 |
| 9 |  AMD ($AMD) gained in premarket trading after Wall Street praised its Advancing AI event, with analysts highlighting stronger-than-expected product announcements and growing confidence in the company's long-term AI roadmap.
The spotlight was on AMD's Helios AI rack-scale platform, next-generation MI455X/MI500 AI GPUs, and Venice CPUs, while the company also raised its AI accelerator market opportunity to $1.4 trillion by 2030.
Analysts pointed to AMD's recent multi-billion-dollar partnership with Anthropic as further validation of its AI strategy, with several firms lifting price targets and reiterating bullish ratings as competition with Nvidia continues to intensify. | 103 |
| 10 |  Meta ($META) launched Seller, a dedicated app for Facebook Marketplace merchants, alongside a free identity verification badge to improve trust and streamline commerce on its platform.
The new app gives sellers AI-powered listing creation, inventory management, buyer messaging, bulk listing tools, and performance analytics.
It syncs seamlessly with existing Marketplace activity and is now available to eligible U.S. iPhone users, with Android testing underway.
Meta also introduced Facebook Verified at no cost, using selfie-based identity verification to help users identify authentic accounts across Marketplace, Groups, Dating, and profiles as AI-generated fake accounts become more prevalent. | 77 |
| 11 |  Nvidia ($NVDA) and South Korea's KAIST are launching a joint AI research lab in Seoul, backed by a planned $300 million investment to accelerate AI innovation tailored to the Korean market.
The lab will focus on developing Korean-language AI models, agent systems, and industry-specific applications, leveraging Nvidia's Nemotron open models and local cloud infrastructure.
The initiative aims to bridge the gap between academic research and real-world deployment, strengthening South Korea's position in the global AI race and expanding Nvidia's influence in one of Asia's most advanced technology ecosystems. | 64 |
| 12 |  Robin Energy ($RBNE) priced an underwritten public offering of 750,000 common shares at $4.00 per share, raising approximately $3 million in gross proceeds before fees and expenses.
The company also granted the underwriter a 45-day option to purchase up to 54,380 additional shares to cover potential over-allotments.
Robin Energy said the proceeds will be used for working capital and general corporate purposes, with the offering expected to close on July 27, 2026. | 59 |
| 13 |  C.H. Robinson ($CHRW) fell in premarket trading after disclosing it could face up to $604 million in compensatory damages following a Texas jury's advisory verdict related to a fatal trucking accident involving a contracted carrier.
The case stems from a multi-vehicle crash in Mississippi that killed three people after a truck operated by Lupus Superior, a carrier hired by C.H. Robinson, collided with multiple vehicles.
The company said it strongly disagrees with the advisory verdict, expects to challenge any final judgment through post-trial proceedings, and plans to appeal if necessary. | 68 |
| 14 |  Charter Communications ($CHTR) fell in premarket trading after losing broadband and video subscribers in Q2, highlighting intensifying competition from lower-cost alternatives, including Starlink.
Spectrum lost 172,000 internet customers and 21,000 video subscribers, contributing to a 2% decline in total revenue and a 4.3% drop in adjusted EBITDA to $5.4 billion.
The bright spot was wireless, where Spectrum Mobile added 406,000 new lines, supported by aggressive promotional offers.
Management remains focused on completing its network evolution initiative by 2027 as it looks to strengthen its long-term competitive position. | 68 |
| 15 |  Stock of the Day: Fortress Biotech ($FBIO)
Fortress Biotech is a high-risk, high-reward biotech company that appears undervalued relative to its balance sheet and portfolio of royalty-generating assets.
The company has a market capitalization of about $132 million, yet ended Q1 2026 with $255.8 million in cash and cash equivalents, following the sale of a Rare Pediatric Disease Priority Review Voucher after the FDA approval of ZYCUBO.
Beyond its strengthened balance sheet, Fortress benefits from Journey Medical, which generates the majority of its commercial revenue, while approved products like ZYCUBO and UNLOXCYT offer future royalty and milestone payment potential.
The key risks remain biotech-related: cash burn, clinical failures, dilution, and the complexity of its holding-company structure.
However, with the stock trading below its cash value and book value, the market may be undervaluing its long-term optionality.
For investors comfortable with small-cap biotech volatility, FBIO remains a speculative Buy. | 63 |
| 16 | Good Morning Traders! Stocks eye tentative recovery post-tech rout as new Trump tariffs hit. Dow futures +0.5%, S&P +0.2%, Nasdaq +0.1%. "Magnificent 7" shed $800B mkt cap Thu. Asia follows suit: KOSPI, Nikkei 📉. 10-12.5% duties on top trade partners ex some energy. PMIs, home sales due. 🧵👇
Here are the highlights for today:
🛢 Oil slips but eyes weekly gain. Brent -2% <$99/bbl after topping $100. WH exempts some products in new tariffs as high crude stirs inflation worry, econ ripples. Bond yields jump to May peaks on fading Fed cut bets. $AXP $NEE $VZ earnings ahead. Macro tea leaves brew.
⚡️ Safety Insurance $SAFT +42% on $1.54B Mapfre all-cash buyout at $105/sh (44% premium). Q1 '27 close seen. To run as Mapfre USA unit post-deal. $AMKR +9% inks multi-yr $NVDA pact on advanced chip pkg/test for AI. AZ capacity boost, US prod ramp, supply chain aid.
☁️ $SAP +6%: Q2 EPS beat, cloud rev +24%, FY outlook hiked. Backlog +26% > est. Cites Autonomous Enterprise strategy, Business AI demand. $INTC +3% on Q2 beat, Q3 guide up. Rev +25% on Client/Data Center AI boom, 41.8% margin > St. Q3 rev seen $15.8-16.8B, EPS $0.38 > consensus.
👎 MaxLinear $MXL -10% despite Q2 beat, Q3 well above St. Q2 rev +55% to $168.8M on datacenter/AI infra. PAM4 DSP platform strength, optical network pipeline grow. Q3 guide midpoint $215M vs $173.8M consensus. Execution overshadows growth. $DECK -3% on FY EPS view < St.
🌎 Trump restores near-global tariff w/ 10-12.5% forced labor duties on 60. Covers 99.4% of imports w/ some exemptions (oil/gas, food, prior 232 targets). USTR: fixes "abuse," levels field. EU: per past US commits. Swiss: at 12.5% cap. UK: no hit. Protests from some. Seen as 301 legal shield.
🏥 $CRM wins $1.6B VA modernization deal. 1yr w/ two 1yr options. Goals: AI-powered 24/7 support, faster vet care via Slack, unified data insights (MuleSoft, Tableau). CEO: eases VA burden, empowers staff, personalizes experience. Cloud contract a boon for CRM govt biz.
🔋 $TSLA woes deepen as Musk's hype wanes. Q2 miss big: $398M op profit vs $1.7B St on mix, credits, costs, R&D despite 480K deliveries (+25%, +80K vs consensus). Megapod data ctr reveal but spending the worry. RBC: robo-taxi, bot key but show me needed. $TSLA -14%. Narrative at risk.
₿ Coinbase $COIN +10% MTD as Clarity Act crypto framework advances. Senate may vote pre-Aug recess. Removes tokens from SEC purview. 64% odds by Apr '26 per Kalshi. Sticking point: Trump conflict ban. D's: enforce post-WH too. R's: partial fix. Bill passage seen unlikely but tone matters.
🎤 D4vd hearing digs into blood evidence to prove teen killing case. DNA said to match in garage, Tesla. Apparent stains on mats, slits from sharp object, luminol glow. 3rd saw not found. Passport in brush 95mi away. 2 Burke area trips seen. Parents in court as defense probes handling.
Who's ready to trade the markets today? Let me see those hands👍👎 | 75 |
| 17 |  $XLE ++4.00%% in 48 days · $CAT ++3.20%% in 6 days — Big Dipper called it. The system identified the dip level and fired the signal at the right price. Free dashboard access available now.
🔗 Get free access: https://www.findbettertrades.com/vote-now-bdt?aff=7101e814b48f2f39d846f83a1847d6c2ddf76e9d3306df9fcb61be9fab4b912c&utm_campaign=bigdipper&utm_source=fbt-social&utm_medium=organic
#BigDipper $XLE $CAT #Trading #SwingTrading | 136 |
| 18 | 📝 Big Dipper Real Wins: XLE, CAT Trades Deliver Gains (July 23, 2026)
XLE & CAT — locked in. See what the Big Dipper booked today.
Read the full article ➜ | 117 |
| 19 |  Northrop Grumman ($NOC) successfully launched its Mission Robotic Vehicle (MRV) alongside three Mission Extension Pods, advancing the company's next-generation on-orbit satellite servicing capabilities.
The MRV is designed to perform missions including satellite inspection, repair, relocation, debris removal, upgrades, and in-space assembly, while the Mission Extension Pods can attach to existing satellites to extend operational life and improve maneuverability.
The spacecraft also carries robotic arms developed by the U.S. Naval Research Laboratory, a Space Force-approved refueling interface, and onboard computing designed to support future AI-enabled autonomous space operations, reinforcing Northrop Grumman's leadership in the emerging in-space servicing market. | 111 |
| 20 |  Johnson & Johnson ($JNJ) reported positive Phase 3 results for its multiple myeloma therapies Tecvayli and Talvey, with the combination significantly improving progression-free survival in patients with relapsed or refractory disease.
The Tecvayli + Talvey regimen reduced the risk of disease progression or death by 89%, outperforming the 73% reduction achieved by Tecvayli + pomalidomide.
Both investigational treatment arms also demonstrated improvements in overall survival.
The study met its primary endpoint, with safety results consistent with the known profiles of both therapies.
Following the strong interim data, the independent monitoring committee recommended early unblinding of the trial. | 79 |
